These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22770444)

  • 41. The dialogue among Islamic countries and groups for a healthy and safe Hajj.
    Salamati P; Naji Z; Koutlaki SA
    Travel Med Infect Dis; 2017; 15():80. PubMed ID: 27773778
    [No Abstract]   [Full Text] [Related]  

  • 42. A University of the Hajj?
    Aljoudi AS
    Lancet; 2013 Nov; 382(9906):1689. PubMed ID: 24267989
    [No Abstract]   [Full Text] [Related]  

  • 43. Real-Time Surveillance of Infectious Diseases, Injuries, and Chronic Conditions During the 2018 Iraq Arba'een Mass Gathering.
    Lami F; Amiri M; Majeed Y; Barr KM; Nsour MA; Khader YS
    Health Secur; 2021; 19(3):280-287. PubMed ID: 33945332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Health risks and advice for Hajj pilgrims].
    Visser H; Lettinga KD; Siegert CE
    Ned Tijdschr Geneeskd; 2011; 155(42):A3962. PubMed ID: 22027471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hazards of hepatitis at the Hajj.
    Rafiq SM; Rashid H; Haworth E; Booy R
    Travel Med Infect Dis; 2009 Jul; 7(4):239-46. PubMed ID: 19717108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Middle East respiratory syndrome coronavirus and the upcoming Hajj.
    Shuman EK
    Int J Occup Environ Med; 2013 Oct; 4(4):169-71. PubMed ID: 24141864
    [No Abstract]   [Full Text] [Related]  

  • 47. The risk of meningococcal disease in travelers and current recommendations for prevention.
    Steffen R
    J Travel Med; 2010; 17 Suppl():9-17. PubMed ID: 20849428
    [No Abstract]   [Full Text] [Related]  

  • 48. Protective practices and respiratory illness among US travelers to the 2009 Hajj.
    Balaban V; Stauffer WM; Hammad A; Afgarshe M; Abd-Alla M; Ahmed Q; Memish ZA; Saba J; Harton E; Palumbo G; Marano N
    J Travel Med; 2012; 19(3):163-8. PubMed ID: 22530823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Public health considerations for mass gatherings in the Middle East and North Africa (MENA) region.
    AlNsour M; Fleischauer A
    East Mediterr Health J; 2013; 19 Suppl 2():S42-7. PubMed ID: 24673098
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention and surveillance of public health risks during extended mass gatherings in rural areas: the experience of the Tamworth Country Music Festival, Australia.
    Polkinghorne BG; Massey PD; Durrheim DN; Byrnes T; MacIntyre CR
    Public Health; 2013 Jan; 127(1):32-8. PubMed ID: 23141111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential risk for drug resistance globalization at the Hajj.
    Al-Tawfiq JA; Memish ZA
    Clin Microbiol Infect; 2015 Feb; 21(2):109-14. PubMed ID: 25682276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.
    Memish ZA; Steffen R; White P; Dar O; Azhar EI; Sharma A; Zumla A
    Lancet; 2019 May; 393(10185):2073-2084. PubMed ID: 31106753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States.
    Memish ZA; Shibl AM
    Travel Med Infect Dis; 2011 Mar; 9(2):60-6. PubMed ID: 21345738
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemic intelligence during mass gatherings.
    Kaiser R; Coulombier D
    Euro Surveill; 2006 Dec; 11(12):E061221.3. PubMed ID: 17213571
    [No Abstract]   [Full Text] [Related]  

  • 55. Meningococcal meningitis group A: a successful control of an outbreak by mass vaccination.
    Bushra HE; Mawlawi MY; Fontaine RE; Afif H
    East Afr Med J; 1995 Nov; 72(11):715-8. PubMed ID: 8904062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health of the Hajj.
    Memish ZA
    Science; 2018 Aug; 361(6402):533. PubMed ID: 30093577
    [No Abstract]   [Full Text] [Related]  

  • 57. As Hajj nears, concerns about public safety linger.
    McCall C
    Lancet; 2016 Sep; 388(10048):950. PubMed ID: 27598667
    [No Abstract]   [Full Text] [Related]  

  • 58. Risk for meningococcal disease associated with the Hajj 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):97-8. PubMed ID: 11263795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serogroup W135 meningococcal disease in Hajj pilgrims.
    Taha MK; Achtman M; Alonso JM; Greenwood B; Ramsay M; Fox A; Gray S; Kaczmarski E
    Lancet; 2000 Dec 23-30; 356(9248):2159. PubMed ID: 11191548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing risks to health and wellbeing at mass gatherings: the role of the Sendai Framework for Disaster Risk Reduction.
    Aitsi-Selmi A; Murray V; Heymann D; McCloskey B; Azhar EI; Petersen E; Zumla A; Dar O
    Int J Infect Dis; 2016 Jun; 47():101-4. PubMed ID: 27062983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.